Asarina Pharma Ab Stock Cash And Equivalents
| ASAP Stock | SEK 0.93 0.04 4.12% |
Asarina Pharma AB fundamentals help investors to digest information that contributes to Asarina Pharma's financial success or failures. It also enables traders to predict the movement of Asarina Stock. The fundamental analysis module provides a way to measure Asarina Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Asarina Pharma stock.
Asarina |
Asarina Pharma AB Company Cash And Equivalents Analysis
Asarina Pharma's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Asarina Pharma Cash And Equivalents | 21.71 M |
Most of Asarina Pharma's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Asarina Pharma AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Asarina Pharma AB has 21.71 M in Cash And Equivalents. This is 97.35% lower than that of the Healthcare sector and 95.14% lower than that of the Biotechnology industry. The cash and equivalents for all Sweden stocks is 99.2% higher than that of the company.
Asarina Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Asarina Pharma's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Asarina Pharma could also be used in its relative valuation, which is a method of valuing Asarina Pharma by comparing valuation metrics of similar companies.Asarina Pharma is rated fourth in cash and equivalents category among related companies.
Asarina Fundamentals
| Return On Equity | -0.7 | |||
| Return On Asset | -0.46 | |||
| Current Valuation | 10.34 M | |||
| Shares Outstanding | 22.64 M | |||
| Shares Owned By Insiders | 38.91 % | |||
| Shares Owned By Institutions | 31.91 % | |||
| Price To Book | 1.17 X | |||
| EBITDA | (37.52 M) | |||
| Net Income | (31.66 M) | |||
| Cash And Equivalents | 21.71 M | |||
| Cash Per Share | 8.04 X | |||
| Total Debt | 5.3 M | |||
| Current Ratio | 18.10 X | |||
| Book Value Per Share | 0.85 X | |||
| Cash Flow From Operations | (42.5 M) | |||
| Earnings Per Share | (1.57) X | |||
| Beta | 0.43 | |||
| Market Capitalization | 29.61 M | |||
| Total Asset | 30.36 M | |||
| Z Score | -0.3 | |||
| Net Asset | 30.36 M |
About Asarina Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Asarina Pharma AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Asarina Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Asarina Pharma AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Asarina Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Asarina Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Asarina Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Asarina Stock
| 0.62 | VOLV-B | AB Volvo | PairCorr |
| 0.62 | VOLV-A | AB Volvo | PairCorr |
| 0.52 | XSPRAY | XSpray Pharma AB | PairCorr |
| 0.5 | ATCO-A | Atlas Copco AB | PairCorr |
| 0.44 | ALIV-SDB | Autoliv | PairCorr |
The ability to find closely correlated positions to Asarina Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Asarina Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Asarina Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Asarina Pharma AB to buy it.
The correlation of Asarina Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Asarina Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Asarina Pharma AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Asarina Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Asarina Pharma AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Asarina Stock analysis
When running Asarina Pharma's price analysis, check to measure Asarina Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Asarina Pharma is operating at the current time. Most of Asarina Pharma's value examination focuses on studying past and present price action to predict the probability of Asarina Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Asarina Pharma's price. Additionally, you may evaluate how the addition of Asarina Pharma to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance |